摘要
目的分析非小细胞肺癌(NSCLC)患者原位肿瘤中浸润T细胞数量与临床转移及患者临床预后的关系。方法选取肺癌组织共140例(其中发生转移的43例),采用免疫组织化学染色法检测肿瘤组织中CD4^+ T细胞和CD8^+ T细胞在肿瘤组织的浸润情况,对比未转移和转移患者肿瘤组织CD4^+T细胞和CD8^+ T细胞的浸润数量,采用生存分析对比不同CD4^+ T细胞和CD8^+ T细胞浸润数量对患者临床预后的影响。结果两组患者肿瘤组织CD4^+ T细胞比例差异不大,转移组患者肿瘤组织CD8^+ T细胞数量显著低于转移组,且未转移组CD8/CD4比例显著高于转移组, CD8^+ T细胞数量多和CD8/CD4比例高的患者总体生存率显著优于CD8^+ T细胞数量少和CD8/CD4比例低的患者。结论出现转移的NSCLC患者肿瘤组织CD8^+ T细胞浸润数量、 CD8/CD4比例均显著下降,与NSCLC转移患者预后差密切相关。
Objective To analyze the relationship between the number of invasive T cells in in situ tumors and the clinical metastasis and prognosis in patients with non-small cell lung cancer(NSCLC). Methods A total of 140 lung cancer patients(including 43 cases with metastasis) were selected to observe the infiltration state of CD4^+ T cells and CD8^+ T cells in tumor tissues by immunohistochemical staining. The infiltration of CD4^+ T cells and CD8^+ T cells were compared between non-metastatic and metastatic patients. The effects of different infiltration levels of CD4^+ T cells and CD8^+ T cells on clinical prognosis were analyzed. Results The proportion of CD4^+ T cells in the tumor tissues of the two groups was not significantly different. The number of CD8^+ T cells in the metastatic group was significantly lower than that in the metastatic group, and the ratio of CD8/CD4 in the non-metastasis group was remarkably higher than that in the metastatic group. Patients with high CD8^+ T cell infiltration level or high ratio of CD8/CD4 have a significantly better overall survival rate than the patients with low CD8^+ T cell infiltration level or low ratio of CD8/CD4. Conclusion The number of CD8^+ T cell infiltration and CD8/CD4 ratio in the tumor tissues of patients with metastatic NSCLC are significantly reduced, which is closely related to the poor prognosis of patients with NSCLC metastasis.
作者
黄柱华
苏文
韩正全
尹靖怡
张玉奇
李小悦
HUANG Zhuhua;SU Wen;HAN Zhengquan;YIN Jingyi;ZHANG Yuqi;LI Xiaoyue(Department of Oncology, First Affiliated Hospital, Bengbu Medical College, Bengbu 233000;Second Affiliated Hospital of Guilin Medical College, Guilin 541199, China)
出处
《细胞与分子免疫学杂志》
CAS
CSCD
北大核心
2019年第3期266-270,共5页
Chinese Journal of Cellular and Molecular Immunology
基金
广西自然科学基金(2017GXNSFBA198044)
广西高校中青年教师基础能力提升项目(2018KY0420)